Introduction: Histological diagnostic of neuroendocrine neoplasms (NEN) relies on morphological criteria and expression of several neuroendocrine marker assessed by immunohistochemistry. Systematic large evaluation of classical (chromogranin A (chrA), synaptophysin (Syn), CD56) and emerging (chromogranin B (chrB), INSM1) markers are lacking.
Aim(s): Assess the diagnostic value of these 5 neuroendocrine markers across a large series of NEN from multiple origins.
Materials and methods: Expression of ChrA (2 most commonly used clones DAK-A3 and LK2H10), Syn, CD56, ChrB and INSM1 was assessed on 466 NEN (including thymus (11), lung (106), digestive system (301) and Merkel cell carcinomas (48). Pancreatic NEN-look alike were also tested (serous cystadenomas (14), acinar cell carcinomas (21), solid pseudopapillary tumors (31). Markers were defined as positive if expressed by at least 10% of the tumor cells.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Pathology - grading, staging
Presenting Author: Dr Jerome Cros
To read results and conclusion, please login ...
Further abstracts you may be interested in